Chemical warheads targeting cancer and inflammatory disorders: MIP: PIQUR Therapeutics AG

• Unité de recherche: INNOSUISSE
• Numéro de projet: 17241.1 PFLS-LS
• Titre du projet anglais: Chemical warheads targeting cancer and inflammatory disorders: MIP: PIQUR Therapeutics AG

Description succincte (Allemand)

Chemical warheads targeting cancer and inflammatory disorders

Description succincte (Anglais)

Chemical warheads targeting cancer and inflammatory disorders: MIP: PIQUR Therapeutics AG

Résumé des résultats (Abstract) (Allemand)

PIQUR and UniBas propose to co-develop a novel strategy to produce covalent inhibitors targeting PI3K/mTOR in cancer and inflammation. The project aims to equip PIQUR with currently unexplored technologyies in the PI3K/mTOR field, and allows UniBas to to study selective PI3K/mTOR-dependent disease mechanisms by Chemical Genetics. Central is entry into uncharted IP space, enlargement of the PIQUR portfolio, the implementation of a proprietary kinase targeting platform, and a highly selective validation of PI3K isoforms as pharmaceutical drug targets.

Résumé des résultats (Abstract) (Anglais)

PIQUR and UniBas propose to co-develop a novel strategy to produce covalent inhibitors targeting PI3K/mTOR in cancer and inflammation. The project aims to equip PIQUR with currently unexplored technologyies in the PI3K/mTOR field, and allows UniBas to to study selective PI3K/mTOR-dependent disease mechanisms by Chemical Genetics. Central is entry into uncharted IP space, enlargement of the PIQUR portfolio, the implementation of a proprietary kinase targeting platform, and a highly selective validation of PI3K isoforms as pharmaceutical drug targets.